Dec 3, 2019 04:01PM
Dec 3, 2019 04:01PM
Nov 5, 2019 04:01PM
Nov 5, 2019 04:01PM
Aug 7, 2019 04:01PM
Aug 7, 2019 04:01PM
Jul 30, 2019 05:21AM Cara Therapeutics (CARA) PT Raised to $39 at Piper Jaffray
Jul 29, 2019 04:01PM
Jul 29, 2019 04:01PM
Jul 25, 2019 05:52AM
Jul 24, 2019 08:42PM
Jul 24, 2019 08:42PM
Jul 24, 2019 04:42PM
Jul 24, 2019 04:01PM Cara Therapeutics Announces Proposed Offering of Common Stock
Jul 24, 2019 04:01PM
Mar 13, 2019 02:37AM
Nov 8, 2018 04:01PM
Nov 8, 2018 04:01PM
Nov 6, 2018 04:01PM
Nov 6, 2018 04:01PM
Aug 7, 2018 04:01PM Cara Therapeutics Reports Second Quarter 2018 Financial Results
Aug 7, 2018 04:01PM
Jul 23, 2018 04:02PM
Jul 23, 2018 04:02PM
Jul 19, 2018 05:49AM
Jul 18, 2018 08:53PM
Jul 18, 2018 08:53PM
Jul 17, 2018 04:25PM Cara Therapeutics (CARA) Announces Proposed 4.5M Share Common Offering
Jul 17, 2018 04:23PM
Jul 17, 2018 04:23PM
Jun 27, 2018 09:25AM
May 30, 2018 06:07AM
Nov 8, 2017 04:01PM
Nov 2, 2017 04:01PM
Jun 30, 2017 08:50AM Cara Therapeutics (CARA): Data Isn't As Bad As It Seems - Piper
Apr 6, 2017 06:37AM
Apr 5, 2017 04:01PM
Mar 31, 2017 05:40AM
Mar 30, 2017 09:35PM
Mar 29, 2017 04:02PM
Mar 29, 2017 04:01PM
Mar 28, 2017 11:54AM Piper Jaffray Reiterates Overweight Rating and $23 PT on Cara Therapeutics (CARA) Following Positive Phase 2/3 Trials of CR845
Mar 10, 2017 07:48AM
Mar 3, 2017 06:10AM
Nov 22, 2016 08:00AM
Nov 15, 2016 06:52AM
Oct 13, 2016 09:20AM
Sep 22, 2016 06:21AM
Apr 21, 2016 07:07AM Piper Jaffray Reiterates Bullish View on Cara Therapeutics (CARA) as Clinical Hold Lifted
Feb 26, 2016 08:37AM

20,859 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All